Loading organizations...
Key people at MTS Health Partners.
MTS Health Partners operates as a specialized boutique investment bank, delivering strategic and financial advisory services exclusively to the healthcare industry. The firm provides guidance on critical transactions and corporate finance matters, leveraging deep sector expertise to support companies through complex market dynamics. Its capabilities extend to offering comprehensive, aligned advice for entities ranging from large global healthcare corporations to emerging venture-backed enterprises.
The company was founded in 1999 by Curtis S. Lane, who serves as a founding partner. Lane established the firm with the insight that the evolving healthcare landscape required a dedicated advisory partner with specific industry knowledge, capable of addressing the unique financial and strategic challenges within the sector. This specialized focus allowed the firm to build tailored solutions for a diverse set of healthcare stakeholders.
MTS Health Partners serves a broad spectrum of clients within healthcare, including established industry leaders and innovative startups seeking financial and strategic development. The firm’s long-term vision centers on continuously expanding its comprehensive coverage and advisory capacity, aiming to remain a pivotal strategic partner in driving growth and facilitating value creation across the entire healthcare ecosystem.
# MTS Health Partners: High-Level Overview
MTS Health Partners is a boutique investment bank specializing exclusively in healthcare advisory and financing services.[1] Founded in 1999, the firm has established itself as a leading strategic and financial advisor to healthcare companies across all sizes—from global public corporations to venture-backed businesses.[1][3] Over 25 years, MTS has executed 282 transactions representing over $121 billion in value for its clients.[1]
The firm's mission centers on fostering trusted client partnerships and providing creative, candid advice that prioritizes long-term strategic alignment over transaction volume.[1] Rather than pushing clients toward deals, MTS positions itself as an objective advisor exploring all available strategic alternatives. This philosophy has made it a trusted partner for healthcare organizations navigating complex M&A, financing, and strategic decisions across biopharmaceuticals, medical technology, life science tools, diagnostics, healthcare technology, and healthcare services.[2]
# Origin Story
MTS Health Partners was founded in 1999 and is headquartered in New York at 623 5th Avenue.[4] The firm was built on the premise that healthcare companies needed dedicated, experienced advisors who understood the sector's unique dynamics and regulatory landscape. Over its 25-year history, MTS has evolved from a boutique advisory shop into a comprehensive investment banking platform, developing deep expertise across multiple healthcare sub-sectors while maintaining its focus on strategic counsel rather than transactional volume.[1][3]
The firm's leadership includes CEO Jay Shiland and CFO Teri Myers, with a team of 201-500 employees generating $50-100 million in annual revenue.[4] The organization has attracted senior personnel with decades of healthcare-focused experience, enabling it to advise on both public and private company transactions at scale.[2]
# Core Differentiators
# Role in the Broader Healthcare Ecosystem
MTS operates at a critical intersection in healthcare finance. As healthcare companies face increasing complexity—from regulatory pressures to consolidation trends to the rise of digital health and biotech innovation—specialized advisory firms have become essential. MTS's exclusive focus on healthcare positions it to understand nuances that generalist banks miss, particularly as healthcare technology, data-driven solutions, and venture-backed innovation reshape the sector.
The firm influences the broader ecosystem by facilitating strategic transactions and capital formation that enable healthcare innovation. By advising companies from early-stage ventures to mature corporations, MTS helps shape industry consolidation patterns, supports emerging technology adoption, and connects capital with healthcare solutions addressing unmet clinical and operational needs.
# Quick Take & Future Outlook
MTS Health Partners is well-positioned to benefit from ongoing healthcare sector dynamics: continued consolidation among healthcare services providers, the maturation of digital health and healthcare technology companies seeking growth capital or strategic exits, and sustained investment in biopharmaceuticals and life science tools. The firm's 25-year track record and deep relationships provide competitive advantages as healthcare companies navigate an increasingly complex landscape.
Looking ahead, MTS's influence will likely grow as healthcare technology and data-driven solutions become central to industry strategy. The firm's ability to advise across traditional healthcare services, emerging technology platforms, and biotech innovation—while maintaining strategic objectivity—positions it as a trusted partner through the sector's ongoing transformation.
Key people at MTS Health Partners.
